Drug Profile
NDDPX 08
Alternative Names: Bromocriptine - Neugen Pharma KK; NDDPX08Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Neugen Pharma
- Class Antidementias; Antihyperglycaemics; Antiparkinsonians; Ergolines; Ergotamines; Infertility therapies; Small molecules
- Mechanism of Action Dopamine D2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Amyotrophic lateral sclerosis
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Amyotrophic-lateral-sclerosis(Adjunctive treatment) in Japan (Parenteral)
- 13 Nov 2010 Pharmacodynamics data from a preclinical trial in Amyotrophic lateral sclerosis presented at the 40th Annual Meeting of the Society for Neuroscience (SFN-2010)
- 13 Nov 2010 Clinical trials in Amyotrophic lateral sclerosis in Japan (Parenteral)